KKR bullish on healthcare, consumer & tech bets in India
Private equity firm KKR is optimistic about investment prospects in India, according to co-CEO Joseph Y Bae. The US company is keen to invest in healthcare, consumer and technology sectors, and interested in India’s privatisation programme. KKR began investing in the country in 2006 and has committed over $10bn there so far, and Bae sees […]
RBI meets foreign banks over ESMA tussle
The move is a fresh step in resolving the issue surrounding the European Securities and Markets Authority’s (ESMA) decision to de-recognise the CCIL following the RBI’s refusal to permit rights of an external regulatory audit. Following a significant softening in the stance of the European regulators, the RBI is said to be more amenable to […]
Fund managers most bearish since Jan on growth uncertainties
The survey showed a net 63% of investors expect a weaker economy – the most pessimistic since December 2022. This has also led to the highest allocation to bond markets, which has seen a 9 percentage points month-on-month to a net 10% under-weight – the highest since March 2009.
FPIs buying into these mid-caps, analysts see up to 50% upside
For instance, the FPI holding in construction firm NCC has increased from 8.89% in March 2022 to 19.96% in March 2023. According to Bloomberg analyst consensus estimates, the stock can yield nearly 15% in a year.
Mankind Pharma announces IPO price band at Rs 1,026-1,080
At the upper end of the price band, the fourth largest pharmaceutical company in terms of domestic sales will be valued at ₹43,264 crore. The four-crore share IPO will be entirely an offer-for-sale (OFS) where existing shareholders will offload a portion of their stakes.
Higher call rates hint at concentration of liquidity with a few large lenders
The weighted average call rate, the target of the Reserve Bank of India’s (RBI) interest rate actions, also climbed above the repo rate, a development that usually occurs when banking system liquidity is in deficit.